CMA veterinary remedies 2026: a plain-English guide for independent practices

On 24 March 2026, the CMA published its final report on UK veterinary services. After more than two years of investigation and 45,000 public submissions, the outcome is 14 binding remedies. The CMA has until 23 September 2026 to put the legal Orders in place, after which compliance is mandatory, enforceable, and on a timetable that differs by practice size and by which remedy applies.

Most of the coverage that followed the March announcement was written either for pet owners or by lawyers for corporate groups. This guide is for independent practice owners and clinical directors who want to understand what changes, when it changes, and what it means inside a real consulting practice, not a legal filing.

We have also covered in detail the prescription fee cap specifically in What the new CMA prescription fee cap means for your practice. For the compliance preparation sequence, read CMA pricing transparency: how to get your practice compliant before the deadlines. This article covers the broader picture.

The 14 remedies: what they cover and when they apply

The CMA grouped its 14 remedies into six categories. The compliance dates vary: pricing transparency and ownership disclosure come first, written estimates and itemised billing follow later. The prescription fee cap sits on its own medicines timeline. None of this is simultaneous, and treating the deadlines as a single event is the most common planning error.

Price lists and pricing transparency

Practices must publish standardised price lists for their most commonly provided services: consultations, routine diagnostics, common procedures, cremation options, and out-of-hours services where relevant. The list needs to be accessible on the practice website and physically displayed at the practice.

Health plans require comparison pricing showing what the same services cost with and without the plan. Parasiticide products must be listed by name, subdivided by size, dosage, and formulation, for those that have sold more than 100 units in the preceding year.

Compliance date: December 2026 for large businesses (15 or more locations), March 2027 for smaller independent practices.

Itemised billing and written estimates

Every invoice must itemise the components of a treatment: consultation fee, diagnostic costs, medication, surgical or procedural charges. A single total or a treatment package line is not sufficient.

For written estimates, the threshold is £500. Any treatment expected to exceed that figure requires a written estimate before proceeding, and an update in writing if the likely cost increases by 20% or £500 during treatment, whichever is lower. Verbal estimates above the threshold do not meet the requirement.

This is the remedy that will require the most operational change for most independent practices. The trigger point, the format, and the record-keeping all need to be defined in advance. The practices that struggle at go-live are almost always the ones that built the process on paper and never tested it in a real consultation.

Compliance date: June 2027 for large businesses, September 2027 for smaller practices.

Prescription fee cap and prescription awareness

Written prescription fees are capped at £21 for the first medicine and £12.50 for additional medicines within the same consultation, adjusted annually for inflation. Practices must also proactively inform clients that written prescriptions are available and that medicines may be significantly cheaper online. That disclosure is mandatory regardless of whether the client asks.

Compliance date: March 2027 for large businesses, September 2027 for smaller practices.

The prescription fee cap and its commercial implications are covered in detail in What the new CMA prescription fee cap means for your practice.

Ownership and corporate disclosure

Practices must state who owns them. Corporate-owned practices must identify their parent group on their website, in-practice signage, and in relevant communications. Independently owned practices must confirm independent status in the same places.

For genuinely independent practices, this is the least burdensome of the compliance requirements and arguably the most commercially useful. A prominent statement of independent ownership communicates something corporate-owned practices cannot: that the practice is locally owned, clinician-led, and not answerable to a group P&L. Many pet owners do not know whether their local practice is independently owned. The disclosure requirement makes independent status visible at no additional cost.

Compliance date: December 2026 for large businesses, March 2027 for smaller practices.

Complaints handling

Practices must have a documented complaints process that clients can access, with defined response timeframes and a route to independent redress for unresolved complaints. For most independent practices, the substance of this is already in place. The compliance requirement formalises it and requires the process to be visible to clients, not just held internally.

Dr Nick Lloyd on what the remedies mean in practice

Of the 14 remedies, prescription awareness will change the consulting room most, and not because it is operationally complex, but because of what it does to the conversation. It brings the subject of price into the clinical interaction in a way that most vets find uncomfortable. There are real emotions attached to that: frustration, sometimes embarrassment. The regulation will not make those feelings disappear, but vets will adapt, and practices that prepare their teams in advance will find the transition far less disruptive than those that do not.

Ownership disclosure is the remedy the CMA got most clearly right. It is also the example that illustrates why external intervention was needed: the profession simply did not have the powers to impose it on itself. For independently owned practices, it is the lowest-effort compliance requirement and, used properly, the most commercially useful one.

I will be direct about something else. Most of the practices I have worked with already had reasonable prescription fees, a complaints process, itemised billing, and published pricing. For those practices, these remedies do not change behaviour. They add administrative burden on top of standards already met. Where the profession genuinely has been slow is in shifting income from products to services as the marketplace changed. Sometimes that has involved profiteering, and we should not pretend otherwise. But for a lot of clinics it has been genuinely difficult: rebalancing toward service fees can threaten viability, and the tools to make that shift were rarely provided by the systems practices were running on. The CMA has forced the direction of travel. The profession now has to find a way to travel it without breaking the practices that were already doing the right thing.

The single most important action right now: talk to your team. Make sure they understand what is coming and when, and give them the actual words to use when a client asks about a written prescription or why the online price is lower. Then, from a business perspective, model the financial impact of losing a proportion of your long-term medication income. Work out what share of your dispensing is repeat, long-term medication that clients could reasonably buy elsewhere, and what that does to your numbers. Far better to do that calculation now, calmly, than to discover the gap after the change has taken effect.

The compliance timeline

Pricing transparency and ownership disclosure arrive first for all practices. The price list, the website ownership statement, and the in-practice signage are the near-term tasks. They require no clinical workflow change.

Written estimates and itemised billing arrive later, but designing the workflow now, before deadline pressure arrives, is the sensible approach. The consultation-room process for triggering an estimate, recording it, and attaching it to the patient record needs to be designed, tested, and embedded before it becomes a mandatory step in every relevant appointment.

For large businesses:

• December 2026: Price lists, ownership disclosure
• March 2027: Prescription fee cap
• June 2027: Written estimates, itemised billing, prescription awareness

For smaller independent practices (fewer than 15 locations):

• March 2027: Price lists, ownership disclosure
• September 2027: Prescription fee cap, written estimates, itemised billing, prescription awareness

What the remedies mean specifically for independent practices

The CMA's investigation was driven substantially by concerns about corporate group consolidation and reduced consumer awareness. The remedies apply equally to all practices, but the experience of complying with them lands differently depending on how a practice is structured.

Larger corporate groups have compliance infrastructure that most independent practices do not. The administration of price list maintenance, invoice configuration, and complaints logging across multiple sites is operationally simpler at scale. For a single-site or small-group independent practice, the same requirements land directly on the clinical director or practice manager alongside everything else they carry.

The CMA's estimated compliance cost of £150 to £250 initial setup and £450 to £550 per year ongoing assumes practices can implement changes using existing systems. For practices whose current PMS does not support itemised invoicing or written estimate workflows adequately, the deadline is a reasonable trigger for reviewing whether a switch makes sense. Lupa OS supports itemised billing, written estimate templates, and structured pricing as part of a connected workflow rather than a separate compliance layer.

The counterweight to the compliance burden is the differentiation opportunity. Ownership disclosure and transparent pricing give independent practices a public, verifiable claim that many corporate-owned practices cannot match. Used well, that is worth more than the cost of the website update.

The RCVS and what comes after the CMA Orders

The CMA has also recommended that government reform the Veterinary Surgeons Act 1966 to give the RCVS powers over veterinary businesses as well as individual practitioners. This is a longer-term structural change and will not arrive within the compliance timelines above. It signals, though, that the regulatory direction of travel is toward greater business-level oversight.

The BVA has an active briefing page for members, and Bird and Bird's practice note covers the legal framework in detail.

Where to start

Work through the requirements in deadline order, not complexity order.

The price list and ownership disclosure come first, both in time and in practical terms. They require the least change to how consultations run. Start with a pricing audit: what your prices actually are across all service categories, whether they are consistent between clinicians, and how your health plan pricing is structured. That audit is the foundation for everything that follows.

The written estimate and itemised billing workflow comes later in the sequence but benefits most from early preparation. Define the trigger, the format, the sign-off, and the record-keeping. Test it. The practices that struggle with written estimates at go-live are the ones that never ran the process through a real consultation before it became mandatory.

For the full preparation sequence, CMA pricing transparency: how to get your practice compliant before the deadlines covers this in detail.

To see how Lupa OS supports itemised billing, written estimate templates, and pricing transparency as part of a connected workflow, book a demo.